Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024
Rhea-AI Summary
Maravai LifeSciences (NASDAQ: MRVI), a global provider of life science reagents and services, has announced its plans to release its third quarter 2024 financial and operating results after market close on Thursday, November 7, 2024. The company will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.
Interested parties can participate in the conference call by dialing (888) 596-4144 or (646) 968-2525 and referencing Maravai LifeSciences, Conference ID 9502421. Additionally, a live or archived webcast of the call will be available on the "Investors" section of the Maravai website at https://investors.maravai.com.
Positive
- None.
Negative
- None.
News Market Reaction – MRVI
In the trading session that priced this news, MRVI declined 0.24%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its third quarter 2024 financial and operating results after the market closes on Thursday, November 7, 2024, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.
To participate in the conference call by telephone, dial (888) 596-4144 or (646) 968-2525 and reference Maravai LifeSciences, Conference ID 9502421. The call will also be available via live or archived webcast on the "Investors" section of the Maravai web site at https://investors.maravai.com.
About Maravai
Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world's leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies.
